GNAS and salivary gland cancer: Moreover, the CSP3 and GSP P16 combination yielded the best performance, with 90.9% sensitivity and 83.3% specificity, outperforming individual probes and other combinations, thereby offering superior detection for malignant salivary gland tumors.